Clinical Trial Update: Allogeneic Transplantation For Severe Osteopetrosis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating allogeneic transplantation for severe osteopetrosis with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopetrosis

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Severe Osteopetrosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-07-31